ゲノム編集/ゲノム工学の世界市場予測(~2022年):技術(CRISPR、TALEN、ZFN)、用途、エンドユーザー

◆英語タイトル:Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs) - Global Forecast 2022
◆発行会社/調査会社:MarketsandMarkets
◆商品コード:BT-3380
◆発行日:2017年11月20日
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆ページ数:166
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[ゲノム編集/ゲノム工学の世界市場予測(~2022年):技術(CRISPR、TALEN、ZFN)、用途、エンドユーザー]についてメールでお問い合わせはこちら
MarketsandMarketsが発行した当調査レポートでは、ゲノム編集/ゲノム工学の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、用途別分析、需要先別分析、地域別分析、ゲノム編集/ゲノム工学の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
*** レポート概要(サマリー)***

The global genome editing/genome engineering market is projected to reach USD 6.28 Billion by 2022 from USD 3.19 Billion in 2017, at a CAGR of 14.5%. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics.
By technology, the genome editing/genome engineering market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In). The CRISPR segment is expected to account for the largest share of the market in 2017. Owing to the factors such as the ease of use associated with the CRISPR technology and the ability of CRISPR to multiplex.

On the basis of application, the genome editing/genome engineering market is segmented into cell line engineering, genetic engineering, and other applications (diagnostics and therapeutics). The cell line engineering segment is expected to account for the largest share of the market in 2017. Factors such as growing industry focus on stem cell research, increasing funding from governments and private organizations, and increasing global awareness about stem cell therapies are driving the growth of the segment.

On the basis of end user, the global genome editing/genome engineering market is segmented into pharmaceutical and biotechnology companies, academic & government research institutes, and contract research organizations. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the global market in 2017. The increasing prevalence of infectious diseases and cancer are driving research activities worldwide; this is expected to drive the demand for genome editing in biotechnology & pharmaceutical companies.

In 2017, North America is expected to account for the largest share of the genome editing/genome engineering market, followed by Europe. Factors such as the development of gene therapy in the US, increasing use of genetically modified crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding are propelling market growth in North America.

Factors such as dearth of skilled professionals and adverse public perception of genetic research are expected to limit the growth of the market to a certain extent.

The prominent players include Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Group (UK), GenScript (US), Sangamo BioSciences (US), Integrated DNA Technologies (US), Lonza Group (Switzerland), New England Biolabs (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland).

*** レポート目次(コンテンツ)***

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Research
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Data Validation and Triangulation
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 28)

4 Premium Insights (Page No. – 32)
4.1 Genome Editing: Market Overview
4.2 Europe: Genome Editing Market, By Application
4.3 Genome Editing Market, By End User
4.4 Genome Editing Market, By Country/Region

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
5.2.1.2 Growing Application Areas of Genomics
5.2.1.3 High Prevalence of Infectious Diseases and Cancer
5.2.1.4 Technological Advancements
5.2.1.5 Increasing Production of Genetically Modified Crops
5.2.2 Restraints
5.2.2.1 Dearth of Trained Professionals
5.2.2.2 Adverse Public Perception of Genetic Research
5.2.3 Opportunities
5.2.3.1 Use of Genome Editing in Specialized/Personalized Medicine
5.2.3.2 Emerging Markets
5.2.4 Challenges
5.2.4.1 High Cost of Genomics Equipment
5.2.4.2 Off-Target Effect of Crispr
5.2.4.3 Secure Storage of Large Volumes of Sequenced Data

6 Genome Editing Market, By Technology (Page No. – 43)
6.1 Introduction
6.2 Crispr
6.3 Talen
6.4 ZFN
6.5 Antisense
6.6 Other Technologies

7 Genome Editing Market, By Application (Page No. – 51)
7.1 Introduction
7.2 Cell Line Engineering
7.3 Genetic Engineering
7.3.1 Animal Genetic Engineering
7.3.2 Plant Genetic Engineering
7.4 Other Applications

8 Genome Editing Market, By End User (Page No. – 60)
8.1 Introduction
8.2 Biotechnology & Pharmaceutical Companies
8.3 Academic & Government Research Institutes
8.4 Contract Research Organizations

9 Genome Editing Market, By Region (Page No. – 65)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Research Grants and Funding By Government Institutes
9.2.1.2 Increasing Use of Gm Crops
9.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias in the US
9.2.1.4 Genome Editing Conferences in the US
9.2.1.5 Increasing Prevalence of Cancer
9.2.1.6 Strategic Developments in the US Market
9.2.2 Canada
9.2.2.1 Availability of Research Funding in Canada
9.2.2.2 Rising Incidence of Cancer
9.2.2.3 Gapp to Intensify Genomic R&D
9.3 Europe
9.3.1 Germany
9.3.1.1 Presence of A Large Number of Academic Institutes
9.3.1.2 Availability of Funding for Life Science Research
9.3.1.3 Conferences/Meetings/Symposiums/Workshops in Germany
9.3.2 UK
9.3.2.1 Increasing Funds and Grants By Government Bodies
9.3.2.2 100,000 Genomes Project in the UK
9.3.3 France
9.3.3.1 Increasing Government Investments in Genomics
9.3.3.2 Introduction of Noninvasive Prenatal Testing in France
9.3.4 RoE
9.3.4.1 Spain’s Focus on Research
9.3.4.2 Growth in the Italian Biotech and Pharma Sectors
9.3.4.3 Growing Research Investments in Sweden & Denmark
9.4 Asia Pacific
9.4.1 China
9.4.1.1 Government Initiatives to Support Healthcare Research in China
9.4.1.2 Efforts of BGI to Boost the Genomics Market in China
9.4.1.3 High Intensity of R&D Activities in China
9.4.2 Japan
9.4.2.1 Increasing Government Focus on Cancer Research
9.4.2.2 Conferences and Symposiums on Genetic Engineering in Japan
9.4.2.3 Focus on Cancer Research and Treatment
9.4.3 India
9.4.3.1 Emergence of Local Players in India Backed By Government Funding
9.4.3.2 Increasing Support for Biotech Start-UPS
9.4.3.3 Growth of the Pharmaceutical Industry in India
9.4.4 RoAPAC
9.4.4.1 Alliances and Partnerships in the Australian Market
9.4.4.2 Genome Asia 100k Initiative
9.4.4.3 Crop Research Initiatives in Asia
9.5 RoW
9.5.1 Latin America
9.5.1.1 Alliances, Availability of Government Funding in Brazil
9.5.1.2 Conferences & Workshops in Brazil (2016-2017)
9.5.2 Middle East and Africa
9.5.2.1 Genetic Testing and Genomic Analysis in the Middle East
9.5.2.2 Rising Prevalence of HIV and Cancer in Africa

10 Competitive Landscape (Page No. – 117)
10.1 Key Developments By Leading Players in the Genome Editing Market (2014-2017)
10.2 Market Share Analysis
10.2.1 Thermo Fisher Scientific
10.2.2 Merck
10.2.3 Horizon Discovery Group
10.3 Competitive Scenario
10.3.1 Agreements, Collaborations, and Partnerships
10.3.2 Product & Service Launches, By Company
10.3.3 Acquisitions
10.3.4 Expansions

11 Company Profiles (Page No. – 125)
(Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
11.1 Thermo Fisher Scientific
11.2 Merck
11.3 Horizon Discovery Group
11.4 Genscript
11.5 Sangamo Biosciences
11.6 Integrated Dna Technologies
11.7 Lonza
11.8 New England Biolabs
11.9 Origene Technologies
11.10 Transposagen Biopharmaceuticals
11.11 Editas Medicine
11.12 Crispr Therapeutics

*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 156)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables (96 Tables)

Table 1 Global Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 2 Crispr-Based Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 3 Talen-Based Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 4 ZFN-Based Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 5 Antisense-Based Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 6 Genome Editing Market for Other Technologies, By Country/Region, 2015–2022 (USD Million)
Table 7 Global Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 8 Genome Editing Market for Cell Line Engineering, By Country, 2015–2022 (USD Million)
Table 9 Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 10 Genome Editing Market for Genetic Engineering, By Country, 2015–2022 (USD Million)
Table 11 Genome Editing Market for Animal Genetic Engineering, By Country, 2015–2022 (USD Million)
Table 12 Genome Editing Market for Plant Genetic Engineering, By Country, 2015–2022 (USD Million)
Table 13 Genome Editing Market for Other Applications, By Country, 2015–2022 (USD Million)
Table 14 Global Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 15 Genome Editing Market for Biotechnology & Pharmaceutical Companies, By Region, 2015–2022 (USD Million)
Table 16 Genome Editing Market for Academic & Government Research Institutes, By Region, 2015–2022 (USD Million)
Table 17 Genome Editing Market for Contract Research Organizations, By Region, 2015–2022 (USD Million)
Table 18 Genome Editing Market, By Region, 2015–2022 (USD Million)
Table 19 Genome Editing Market, By Country/Region, 2015–2022 (USD Million)
Table 20 North America: Genome Editing Market, By Country, 2015–2022 (USD Million)
Table 21 North America: Genome Engineering Market, By Technology, 2015–2022 (USD Million)
Table 22 North America: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 23 North America: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 24 North America: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 25 US: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 26 US: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 27 US: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 28 US: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 29 Indicative List of Projects Funded By Gapp in 2014
Table 30 Canada: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 31 Canada: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 32 Canada: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 33 Canada: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 34 Conference, Meeting, Course and Workshop in Europe (2014-2018)
Table 35 Europe: Genome Editing Market, By Country, 2015–2022 (USD Million)
Table 36 Europe: Genome Engineering Market, By Technology, 2015–2022 (USD Million)
Table 37 Europe: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 38 Europe: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 39 Europe: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 40 Conferences, Meetings, Symposiums, Workshops in Germany (2014-2018)
Table 41 Germany: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 42 Germany: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 43 Germany: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 44 Germany: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 45 UK: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 46 UK: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 47 UK: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 48 UK: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 49 France: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 50 France: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 51 France: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 52 France: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 53 RoE: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 54 RoE: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 55 RoE: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 56 France: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 57 Asia Pacific: Genome Editing Market, By Country, 2015–2022 (USD Million)
Table 58 Asia Pacific: Genome Engineering Market, By Technology, 2015–2022 (USD Million)
Table 59 Asia Pacific: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 60 Asia Pacific: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 61 Asia Pacific: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 62 China: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 63 China: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 64 China: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 65 China: Genome Engineering Market, By End User, 2015–2022 (USD Million)
Table 66 Conferences, Symposia, & Workshops in Japan, 2016-2018
Table 67 Japan: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 68 Japan: Genome Engineering Market, By Application, 2015–2022 (USD Million)
Table 69 Japan: Genome Engineering Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 70 Japan: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 71 India: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 72 India: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 73 India: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 74 Europe: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 75 RoAPAC: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 76 RoAPAC: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 77 RoAPAC: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 78 RoAPAC: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 79 RoW: Genome Editing Market, By Region, 2015–2022 (USD Million)
Table 80 RoW: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 81 RoW: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 82 RoW: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 83 RoW: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 84 Latam: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 85 Latam: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 86 Latam: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 87 Latam: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 88 HIV Infections and Aids-Related Deaths in the Middle East and Africa, 2014
Table 89 MEA: Genome Editing Market, By Technology, 2015–2022 (USD Million)
Table 90 MEA: Genome Editing Market, By Application, 2015–2022 (USD Million)
Table 91 MEA: Genome Editing Market for Genetic Engineering, By Type, 2015–2022 (USD Million)
Table 92 MEA: Genome Editing Market, By End User, 2015–2022 (USD Million)
Table 93 Agreements, Collaborations, and Partnerships, By Company (2015–2017)
Table 94 Product & Service Launches, By Company (2015–2017)
Table 95 Acquisitions, By Company (2015–2017)
Table 96 Expansions, By Company (2015–2017)

List of Figures (42 Figures)

Figure 1 Global Genome Editing Market Segmentation
Figure 2 Global Genome Editing Market: Research Methodology Steps
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Bottom-Up Approach
Figure 6 Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Global Genome Editing Market, By Technology (2017–2022)
Figure 9 Global Genome Editing Market, By Application, 2017 vs 2022 (USD Million)
Figure 10 Global Genome Editing Market, By End User, 2017 vs 2022 (USD Million)
Figure 11 Geographical Snapshot of the Genome Editing Market
Figure 12 Rising Government Funding and High Prevalence of Infectious Diseases & Cancer—Key Growth Drivers of the Genome Editing Market
Figure 13 Cell Line Engineering Segment to Account for the Largest Market Share in 2017
Figure 14 Biotechnology & Pharmaceutical Companies Will Continue to Dominate the Genome Editing Market in 2022
Figure 15 North America to Register the Highest CAGR in the Forecast Period
Figure 16 Genome Editing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Global Genome Editing Market, By Technology, 2017 vs 2022 (USD Million)
Figure 18 Global Genome Editing Market, By Application, 2017 vs 2022 (USD Million)
Figure 19 Genome Editing Market for Genetic Engineering, By Type, 2017 vs 2022 (USD Million)
Figure 20 Genome Editing Market, By End User, 2017 vs 2022 (USD Million)
Figure 21 Genome Editing Market, By Region, 2017 vs 2022 (USD Million)
Figure 22 North America: Genome Editing Market Snapshot
Figure 23 North Amarica: Number of New Cancer Cases, By Country
Figure 24 Prevalence of Alzheimer's Disease in the US, By Age (2016)
Figure 25 Europe: Genome Editing Market Snapshot
Figure 26 Europe: Number of New Cancer Cases, By Country
Figure 27 Asia Pacific: Genome Editing Market Snapshot
Figure 28 APAC: Number of New Cancer Cases, By Type
Figure 29 RoW: Genome Editing Market Snapshot
Figure 30 Market Share Analysis, By Key Player, 2016
Figure 31 Agreements, Collaborations, and Partnerships—Key Growth Strategy Adopted By Market Players
Figure 32 Agreements, Collaborations, and Partnerships, By Company (2014–2017)
Figure 33 Product & Service Launches, By Company (2014-2017)
Figure 34 Acquisitions, By Company (2014–2017)
Figure 35 Expansions, By Company (2014–2017)
Figure 36 Thermo Fisher Scientific: Company Snapshot
Figure 37 Merck: Company Snapshot
Figure 38 Horizon Discovery: Company Snapshot
Figure 39 Genscript : Company Snapshot
Figure 40 Sangamo Biosciences: Company Snapshot
Figure 41 Lonza: Company Snapshot
Figure 42 Editas Medicine: Company Snapshot

*** レポートのキーワード ***

ゲノム編集、ゲノム工学、ゲノム編集技術、CRISPR、TALEN、ZFN、ゲノム編集用途、細胞株、遺伝子

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(BT-3380 )"ゲノム編集/ゲノム工学の世界市場予測(~2022年):技術(CRISPR、TALEN、ZFN)、用途、エンドユーザー" (英文:Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs) - Global Forecast 2022)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。